268 related articles for article (PubMed ID: 28780632)
1. HSP90: a promising broad-spectrum antiviral drug target.
Wang Y; Jin F; Wang R; Li F; Wu Y; Kitazato K; Wang Y
Arch Virol; 2017 Nov; 162(11):3269-3282. PubMed ID: 28780632
[TBL] [Abstract][Full Text] [Related]
2. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance.
Geller R; Vignuzzi M; Andino R; Frydman J
Genes Dev; 2007 Jan; 21(2):195-205. PubMed ID: 17234885
[TBL] [Abstract][Full Text] [Related]
3. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection.
Lubkowska A; Pluta W; Strońska A; Lalko A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502274
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses.
Connor JH; McKenzie MO; Parks GD; Lyles DS
Virology; 2007 May; 362(1):109-19. PubMed ID: 17258257
[TBL] [Abstract][Full Text] [Related]
5. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
Lu CY; Chang YC; Hua CH; Chuang C; Huang SH; Kung SH; Hour MJ; Lin CW
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468311
[TBL] [Abstract][Full Text] [Related]
6. Broad action of Hsp90 as a host chaperone required for viral replication.
Geller R; Taguwa S; Frydman J
Biochim Biophys Acta; 2012 Mar; 1823(3):698-706. PubMed ID: 22154817
[TBL] [Abstract][Full Text] [Related]
7. Development and application of Hsp90 inhibitors.
Solit DB; Chiosis G
Drug Discov Today; 2008 Jan; 13(1-2):38-43. PubMed ID: 18190862
[TBL] [Abstract][Full Text] [Related]
8. Implication of B23/NPM1 in Viral Infections, Potential Uses of B23/NPM1 Inhibitors as Antiviral Therapy.
Lobaina Y; Perera Y
Infect Disord Drug Targets; 2019; 19(1):2-16. PubMed ID: 29589547
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of virus replication: recent developments and prospects.
Magden J; Kääriäinen L; Ahola T
Appl Microbiol Biotechnol; 2005 Mar; 66(6):612-21. PubMed ID: 15592828
[TBL] [Abstract][Full Text] [Related]
10. Hsp90 inhibitor reduces porcine circovirus 2 replication in the porcine monocytic line 3D4/31.
Liu J; Zhang X; Ma C; Jiang P; Yun S
Virus Genes; 2017 Feb; 53(1):95-99. PubMed ID: 27557816
[TBL] [Abstract][Full Text] [Related]
11. Marine alkaloid oroidin analogues with antiviral potential: A novel class of synthetic compounds targeting the cellular chaperone Hsp90.
Lillsunde KE; Tomašič T; Kikelj D; Tammela P
Chem Biol Drug Des; 2017 Dec; 90(6):1147-1154. PubMed ID: 28580714
[TBL] [Abstract][Full Text] [Related]
12. The cellular chaperone heat shock protein 90 facilitates Flock House virus RNA replication in Drosophila cells.
Kampmueller KM; Miller DJ
J Virol; 2005 Jun; 79(11):6827-37. PubMed ID: 15890922
[TBL] [Abstract][Full Text] [Related]
13. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
14. Role of heat-shock protein 90 in hepatitis E virus capsid trafficking.
Zheng ZZ; Miao J; Zhao M; Tang M; Yeo AE; Yu H; Zhang J; Xia NS
J Gen Virol; 2010 Jul; 91(Pt 7):1728-36. PubMed ID: 20219895
[TBL] [Abstract][Full Text] [Related]
15. Polyamines and Their Role in Virus Infection.
Mounce BC; Olsen ME; Vignuzzi M; Connor JH
Microbiol Mol Biol Rev; 2017 Dec; 81(4):. PubMed ID: 28904024
[TBL] [Abstract][Full Text] [Related]
16. Hsp90 inhibitors reduce influenza virus replication in cell culture.
Chase G; Deng T; Fodor E; Leung BW; Mayer D; Schwemmle M; Brownlee G
Virology; 2008 Aug; 377(2):431-9. PubMed ID: 18570972
[TBL] [Abstract][Full Text] [Related]
17. Viral infections and sphingolipids.
Schneider-Schaulies J; Schneider-Schaulies S
Handb Exp Pharmacol; 2013; (216):321-40. PubMed ID: 23563664
[TBL] [Abstract][Full Text] [Related]
18. Proteostasis in Viral Infection: Unfolding the Complex Virus-Chaperone Interplay.
Aviner R; Frydman J
Cold Spring Harb Perspect Biol; 2020 Mar; 12(3):. PubMed ID: 30858229
[TBL] [Abstract][Full Text] [Related]
19. [Prospects and current data in antiviral chemotherapy].
Huraux JM; Ingrand D; Agut H; Devillechabrolle A
Rev Pneumol Clin; 1989; 45(3):99-105. PubMed ID: 2685967
[TBL] [Abstract][Full Text] [Related]
20. The future of antivirals: broad-spectrum inhibitors.
Debing Y; Neyts J; Delang L
Curr Opin Infect Dis; 2015 Dec; 28(6):596-602. PubMed ID: 26524332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
